The Challenge of Change - Managing Excipients Control
Colorcon
19-Sep-2011 - Use of deoxycholate to chemically disrupt influenza viruses during vaccine manufacture could be linked to adverse reactions in children, a journal reports.
14-Sep-2011 - Albemarle says it will increase what it charges for generic APIs from next month, citing increasing regulatory and testing costs as the main reasons for the hike.
14-Sep-2011 - Biocon has begun work on the Malaysian biopharm plant that will serve its deal with Pfizer, and is now providing Lipitor ingredients.
13-Sep-2011 - Contract manufacturer CMC Biologics has ramped-up bioreactor capacity to meet demand for biologic drugs for Phase III clinical trials and beyond.
12-Sep-2011 - in-PharmaTechnologist presents a roundup of recent ingredient and formulation research, including using NIR-CI to check quality and microwaves to formulate ibuprofen.
12-Sep-2011 - Lonza Group and Fosun Pharmaceuticals will pump $15.6m (100m yuan) into a joint venture in the Zhangjiang High-Tech Industry Zone, China.
12-Sep-2011 - Lanxess have begun plans to increase its production of thionyl chloride by 20 per cent at its plant in Nagda, India.
08-Sep-2011 - Contract manufacturing organisation (CMO) Aurobindo Pharma has teamed up with Russian supplement maker OJSC Diod to establish a manufacturing joint-venture.
08-Sep-2011 - Privately-owned US biotech NanoSmart Pharmaceuticals says it has started work on a delivery platform for cancer drugs after moving into a new corporate HQ.
07-Sep-2011 - Marina Biotech has strengthened its nucleic acid-peptide drug delivery platform after being granted the allowance for patents application of a library of novel peptides.
07-Sep-2011 - AmerisourceBergen has bought informatics firm IntrinsiQ for $35m (€25m) continuing the spending spree it began earlier this week with the acquisition of market access consultancy Premier Source.
06-Sep-2011 - Researchers at the University of Nottingham, UK, are using a harmless bacteria found in soil as a drug delivery vehicle for oncology.
06-Sep-2011 - Japanese CMO Toyobo says it will increase capacity for injectable drugs to secure its position as a service provider in the expanding biopharmaceutical sector.
01-Sep-2011 - Royal DSM and Sinochem’s anti-infective manufacturing and distribution JV in China has been given the green light by competition authorities.
31-Aug-2011 - DMV-Fonterra excipients (DFE) will buy Indian manufacturer Brahmar Cellulose Private Limited (BCPL) to strengthen its position in the pharmaceutical excipient market and reduce costs.
31-Aug-2011 - German chemical maker Wacker Chemie is ramping up its sales operations in India, with the country’s rapidly expanding pharmaceutical sector being one of its key targets.
30-Aug-2011 - Chemicals giant BASF has increased the price of drug APIs and excipients by 10 per cent for the second time in a year.
30-Aug-2011 - Stellar Biotechnologies is to scale up its aquaculture limpet farms for commercial supply of a vaccine component after receiving a US grant.
29-Aug-2011 - Chemicals maker Granules India says it will expand manufacturing capacity for oral solid dose (OSD) APIs and drug intermediates in a bid to better meet the needs of clients.
29-Aug-2011 - in-PharmaTechnologist presents a roundup of the latest drug delivery research, including bone marrow targeting nanoparticles and an imaging-treatment combo.
25-Aug-2011 - US chemicals maker Ashland says completion of ISP takeover means simplified supply chains for drug and cosmetics industry customers.
25-Aug-2011 - Drug delivery and pharmaceutical coating specialists SurModics are set to cut nine per cent of staff in a reshuffle of the business.
25-Aug-2011 - Irvine Scientific has begun shipping from the cell culture media plant it built to expand into Asia and give clients the security of a second source.
24-Aug-2011 - The UAE needs overseas investment to kick-start its pharmaceutical manufacturing sector and end reliance on foreign imports, the DCCI says.
23-Aug-2011 - Catalent is to buy clinical trial supply assets from Aptuit for $410m (€285m) as it adds scale to handle the shift to preferred provider relationships.